A novel approach to "neutralization" of preformed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant transplantation.
Cooper
D K
DK
Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City 73112.
Ye
Y
Y
Kehoe
M
M
Niekrasz
M
M
Rolf
L L
LL
Martin
M
M
Baker
J
J
Kosanke
S
S
Zuhdi
N
N
Worsley
G
G
D000017:ABO Blood-Group System / Q000276:immunology*; D000818:Animals; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001379:Azathioprine / Q000627:therapeutic use; D001788:Blood Grouping and Crossmatching; D002240:Carbohydrate Sequence; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D007075:Immunoglobulin M / Q000032:analysis*; D007165:Immunosuppression Therapy / Q000379:methods; D008775:Methylprednisolone / Q000627:therapeutic use; D008954:Models, Biological; D008969:Molecular Sequence Data; D010215:Papio; D014183:Transplantation, Heterologous / Q000276:immunology; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous / Q000276:immunology; D014312:Trisaccharides / Q000008:administration & dosage / Q000276:immunology*
D000017:ABO Blood-Group System; D000936:Antigen-Antibody Complex; D007075:Immunoglobulin M; D014312:Trisaccharides; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone